Trial Profile
Study of the Pharmacogenomics in Italian Hypertensive patients treated with the Angiotensin receptor blocker losartan (SOPHIA)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Sep 2015
Price :
$35
*
At a glance
- Drugs Losartan (Primary) ; Hydrochlorothiazide
- Indications Essential hypertension
- Focus Pharmacogenomic; Therapeutic Use
- Acronyms SOPHIA
- 03 Dec 2007 New trial record.